In the News | Friends of Cancer Research

You are here

In the News

February 1, 2009
Application of systems biology methods to evaluate toxicities in oncology treatments can accelerate the introduction of safe, effective drugs. We are organizing a pilot study to utilize a systems... Read more
January 30, 2009
WASHINGTON, Jan 30 (Reuters) - President Barack Obama plans to announce soon his pick to head the U.S. Food and Drug Administration to help create a new regulatory structure to protect the nation's... Read more
January 27, 2009
House and Senate Stimulus Bills To Include $3.5 billion for NIH, $1.1 billion for Comparative Clinical Effectiveness The House of Representatives and Senate released a draft of their economic... Read more
January 27, 2009
Medicare, with little public debate, has expanded its coverage of drugs for cancer treatments not approved by the Food and Drug Administration. Cancer doctors had clamored for the changes, saying... Read more
January 23, 2009
The Obama administration has appointed an infectious disease and disaster preparedness expert as acting director of the U.S. Centers for Disease Control and Prevention. Richard Besser, who headed the... Read more
January 16, 2009
The House of Representatives and Senate released a draft of their economic stimulus packages titled "the American Recovery and Reinvestment Act of 2009."  ***Senator Specter plans to offer an... Read more
January 12, 2009
The transition team for President-elect Barack Obama, hoping to make a swift break in Bush administration policies at the Centers for Disease Control and Prevention and the Food and Drug... Read more
January 11, 2009
Friends of Cancer Research Brings in 2009 with a New Website  Friends of Cancer Research brought in the New Year with a newly designed website, The new site, launched at the end... Read more
January 8, 2009
Former Senator Tom Daschle pledged on Thursday to work with lawmakers of both parties in a grass roots, ideology-free campaign to revamp the nation’s struggling health care system.  “We will be... Read more
December 26, 2008
A patient is diagnosed with non-small-cell lung cancer. A DNA test costing $1,000 reveals the subtype of his cancer. The test indicates that the most effective treatment will be an oral drug rather... Read more